ADMA Biologics Inc

ADMA Biologics Insider Moves: RSU Incentives, Strategic Focus & Market Outlook

ADMA Biologics insider trades reveal CFO RSU boost and strategic plasma‑derived focus—key insights for investors on long‑term growth and market sentiment.

ADMA Biologics Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

27/02/2026, 03:16

5 minutes to read

ADMA Biologics Insider Buys 91,631 Shares—Signal of Strong Corporate Confidence

ADMA Biologics insider buy‑side move: COO Kaitlin Kestenberg‑Messina buys 91,631 shares, signaling leadership confidence amid regulatory milestones and market volatility.

ADMA Biologics Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

12/02/2026, 03:16

4 minutes to read